PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Cabaletta Bio, Inc. (CABA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US12674W1099

CUSIP

12674W109

Sector

Healthcare

IPO Date

Oct 25, 2019

Highlights

Market Cap

$91.40M

EPS (TTM)

-$2.16

Total Revenue (TTM)

$4.01M

Gross Profit (TTM)

$2.86M

EBITDA (TTM)

-$113.35M

Year Range

$1.76 - $26.35

Target Price

$22.10

Short %

7.84%

Short Ratio

4.26

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
CABA vs. CATH CABA vs. OLMA CABA vs. SANA
Popular comparisons:
CABA vs. CATH CABA vs. OLMA CABA vs. SANA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cabaletta Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-83.32%
12.93%
CABA (Cabaletta Bio, Inc.)
Benchmark (^GSPC)

Returns By Period

Cabaletta Bio, Inc. had a return of -91.76% year-to-date (YTD) and -89.86% in the last 12 months.


CABA

YTD

-91.76%

1M

-56.41%

6M

-83.32%

1Y

-89.86%

5Y (annualized)

-32.47%

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

24.72%

1M

1.67%

6M

12.93%

1Y

30.55%

5Y (annualized)

13.88%

10Y (annualized)

11.16%

Monthly Returns

The table below presents the monthly returns of CABA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-9.78%11.72%-25.44%-37.60%-4.27%-26.59%-5.08%-20.70%-16.16%-24.79%-91.76%
202331.78%-27.48%-6.45%25.51%-2.79%27.95%5.50%3.96%7.49%-6.31%12.55%41.43%145.41%
2022-20.32%-28.48%-6.02%-32.02%-7.25%-17.19%11.32%-19.07%-31.94%160.00%165.09%106.47%144.06%
20214.41%-16.58%2.12%0.27%1.89%-24.16%-13.26%36.46%19.45%12.42%-15.29%-67.27%-69.63%
202017.61%-9.07%-51.14%-0.68%17.93%30.29%2.60%-7.70%2.75%6.73%28.61%-16.13%-10.67%
20195.00%30.48%1.97%39.70%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CABA is 3, indicating that it is in the bottom 3% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of CABA is 33
Combined Rank
The Sharpe Ratio Rank of CABA is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of CABA is 11
Sortino Ratio Rank
The Omega Ratio Rank of CABA is 22
Omega Ratio Rank
The Calmar Ratio Rank of CABA is 11
Calmar Ratio Rank
The Martin Ratio Rank of CABA is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for CABA, currently valued at -0.93, compared to the broader market-4.00-2.000.002.004.00-0.932.54
The chart of Sortino ratio for CABA, currently valued at -2.26, compared to the broader market-4.00-2.000.002.004.00-2.263.40
The chart of Omega ratio for CABA, currently valued at 0.72, compared to the broader market0.501.001.502.000.721.47
The chart of Calmar ratio for CABA, currently valued at -0.96, compared to the broader market0.002.004.006.00-0.973.66
The chart of Martin ratio for CABA, currently valued at -1.54, compared to the broader market0.0010.0020.0030.00-1.5416.26
CABA
^GSPC

The current Cabaletta Bio, Inc. Sharpe ratio is -0.93. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Cabaletta Bio, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.93
2.54
CABA (Cabaletta Bio, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Cabaletta Bio, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-92.63%
-0.88%
CABA (Cabaletta Bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cabaletta Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cabaletta Bio, Inc. was 96.63%, occurring on Sep 23, 2022. Recovery took 294 trading sessions.

The current Cabaletta Bio, Inc. drawdown is 92.63%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.63%Jan 30, 2020669Sep 23, 2022294Nov 24, 2023963
-92.63%Feb 9, 2024199Nov 21, 2024
-55.51%Nov 20, 201916Dec 12, 201931Jan 29, 202047
-26.79%Nov 28, 20231Nov 28, 202311Dec 13, 202312
-19.64%Jan 9, 20248Jan 19, 202414Feb 8, 202422

Volatility

Volatility Chart

The current Cabaletta Bio, Inc. volatility is 38.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
38.06%
3.96%
CABA (Cabaletta Bio, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cabaletta Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Cabaletta Bio, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items